Back to basics as I break down a trial

I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more.

I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya.

I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system.

I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints.

I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%.

I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!

The entire healthcare system is broken, it's not just health insurance companies.

Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.

Our 2 hour critical appraisal and ASH review. SO many guest stars

Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024.

Timothee Olivier and I discuss the top ESMO 2024 abstracts!

AI in healthcare - my latest keynote address

"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics program.

Screening/ Drug efficacy/ Sotorasib/ Adaura and more

My UCSF lecture on driver mutation lung cancer

We break down the best studies from ASCO

Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session

What you need to know in advance of ASCO

Should trials have carbon footprint as an endpoint?